Gene: HYCC2
Official Full Name: hyccin PI4KA lipid kinase complex subunit 2provided by HGNC
Gene Summary: Predicted to be involved in phosphatidylinositol phosphate biosynthetic process and protein localization to plasma membrane. Predicted to be located in cytosol and membrane. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17037 | HYCC2 Knockout cell line (HeLa) | Human | HYCC2 | 1:3~1:6 | Negative | Online Inquiry |
KO17038 | HYCC2 Knockout cell line (HCT 116) | Human | HYCC2 | 1:2~1:4 | Negative | Online Inquiry |
KO17039 | HYCC2 Knockout cell line (HEK293) | Human | HYCC2 | 1:3~1:6 | Negative | Online Inquiry |
KO17040 | HYCC2 Knockout cell line (A549) | Human | HYCC2 | 1:3~1:4 | Negative | Online Inquiry |
HYCC2 Gene Knockout Cell Lines are genetically modified cell cultures that have undergone targeted gene disruption of the HYCC2 gene, allowing researchers to investigate the functional role of this specific gene in cellular processes. These cell lines serve as invaluable tools for elucidating gene function, disease mechanisms, and potential therapeutic pathways, providing researchers with a robust platform for studying gene expression and cellular responses to various stimuli.
The primary function of the HYCC2 gene knockout model is to facilitate the examination of how the absence of this particular gene influences cellular behavior, signaling pathways, and gene regulatory networks. Mechanistically, the knockout is achieved through cutting-edge CRISPR/Cas9 technology, which enables precise editing of the genome, thereby leading to a loss-of-function mutation. This methodology ensures that any observed phenotypic changes can be directly attributed to the gene's disruption, empowering researchers to draw meaningful conclusions from their experiments.
Scientifically, the HYCC2 Gene Knockout Cell Lines hold immense importance in both basic and applied research. They can be used in studies related to cancer biology, developmental biology, and pharmacology, providing insights into the roles of specific genes in disease development and potential drug targets. Moreover, these cell lines have applications in the screening of small molecules and testing of therapeutic agents, making them essential tools in translational medicine.
Comparatively, HYCC2 Gene Knockout Cell Lines stand out among other gene knockout models due to their exceptional reliability and reproducibility, stemming from standardized production protocols and rigorous quality controls. They are designed for ease of use, allowing for rapid implementation in experimental workflows, and include detailed user documentation to support researchers from diverse fields.
The value of HYCC2 Gene Knockout Cell Lines extends beyond mere research applications; they represent a significant leap forward in our understanding of gene function and its implications in health and disease. By utilizing these cell lines, researchers and clinicians can accelerate their studies, fostering innovations in gene therapy, personalized medicine, and other therapeutic strategies.
Our commitment to providing high-quality biological products reflects our extensive expertise in genetic engineering and cell biology. With continuous advancements in our offerings, we ensure that our customers are equipped with the tools they need to make groundbreaking discoveries in their respective fields.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.